Literature DB >> 31141158

Electron microscopy in the diagnosis of Ehlers-Danlos syndromes: correlation with clinical and genetic investigations.

C Angwin1, N Ghali1, D Baker2, A F Brady1, F M Pope3, A Vandersteen4, B Wagner5, D J P Ferguson6,7, F S van Dijk1.   

Abstract

BACKGROUND: The Ehlers-Danlos syndromes (EDS) consist of 13 subtypes with overlapping features including joint hypermobility, skin and vascular fragility and generalized connective tissue friability. As DNA analysis has become the gold standard for investigation of EDS, transmission electron microscopy (TEM) in clinical practice is decreasing. However, owing to the use of next-generation sequencing, the frequency of variants of uncertain significance (VUS) identified using DNA analysis is increasing. We hypothesized that TEM can provide evidence for or against pathogenicity of VUS.
OBJECTIVES: The aim of this study was to evaluate the role of TEM in the diagnosis of EDS subtypes.
METHODS: Data were collected from patients who underwent a skin biopsy between October 2012 and March 2017 at the London EDS National Diagnostic Service. TEM biopsies were categorized as 'normal' or 'abnormal' according to the description and conclusion in the TEM reports. Definitive diagnoses were reached via a combination of clinical features, structural and functional studies and DNA investigations.
RESULTS: The analysis included 177 patients, comprising 30 abnormal and 147 normal TEM reports. A definitive diagnosis of monogenic EDS subtypes was made in 24 patients. Overall, 17 of these 24 patients (71%) had an abnormal biopsy report and seven (29%) had a normal biopsy report. No TEM findings were specifically associated with any EDS subtype, although collagen flowers were present in most patients with a genetically confirmed diagnosis of classical EDS.
CONCLUSIONS: TEM analysis of collagen structure may have the potential to provide evidence for or against the pathogenicity of a VUS, but more work is needed to establish a clear role for TEM in this process. What's already known about this topic? Collagen fibril abnormalities can be seen in several Ehlers-Danlos syndrome (EDS) subtypes. What does this study add? This study provides clinical data, transmission electron microscopy (TEM) data and molecular data of one of the largest groups of patients suspected to have a monogenetic EDS subtype. No TEM findings were specifically associated with an EDS subtype. There was a higher percentage (71%) of abnormal biopsy findings in patients with a definitive diagnosis of a monogenetic EDS subtype and where a class 4/5 genetic variant was present.
© 2019 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31141158     DOI: 10.1111/bjd.18165

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Independent COL5A1 Variants in Cats with Ehlers-Danlos Syndrome.

Authors:  Sarah Kiener; Neoklis Apostolopoulos; Jennifer Schissler; Pascal-Kolja Hass; Fabienne Leuthard; Vidhya Jagannathan; Carole Schuppisser; Sara Soto; Monika Welle; Ursula Mayer; Tosso Leeb; Nina M Fischer; Sabine Kaessmeyer
Journal:  Genes (Basel)       Date:  2022-04-29       Impact factor: 4.141

Review 2.  The Role of Cell Adhesion and Cytoskeleton Dynamics in the Pathogenesis of the Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders.

Authors:  Sabeeha Malek; Darius V Köster
Journal:  Front Cell Dev Biol       Date:  2021-04-21

Review 3.  The Relevance of Skin Biopsies in General Internal Medicine: Facts and Myths.

Authors:  Sophie Bailleux; Patrick Collins; Arjen F Nikkels
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-17

Review 4.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

5.  A novel mutation in COL3A1 associates to vascular Ehlers-Danlos syndrome with predominant musculoskeletal involvement.

Authors:  Federica Ruscitti; Lucia Trevisan; Giulia Rosti; Fabio Gotta; Annalia Cianflone; Alessandro Geroldi; Paola Origone; Anna Pichiecchio; Simona Viglio; Maria Iascone; Paola Mandich
Journal:  Mol Genet Genomic Med       Date:  2021-07-28       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.